Vitexicarpin Directly Targets RSK2 to Attenuate Migration and Invasion of Triple‐Negative Breast Cancer Through Modulating HIF‐1α/MMP‐9 Pathway
Year: 2026
Type: article
Source: Drug Development Research
DOI: 10.1002/ddr.70291
Authors: Shuhui You, Tianhui Wu, Min Qian, Jiahui Du, Wenbing Sun, Mengyao Li, Xiaocan Zhang, Yuyang Zhou, Liangzhi Li, Min Xiang, Weiqiang Guo
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Awards: G7378934176, G7990234199
OpenAlex ID: W7156262181
